Abbott announces prices for $2.78 billion redemption of notes series

By Ashley Montgomery

Kansas City, Kan., Dec. 7 - Abbott Laboratories released the redemption prices for its 4.35% notes due 2014, 2.7% notes due 2015, 5.875% notes due 2016 and 5.6% notes due 2017, according to a series of notices.

The following remaining notes will be redeemed on Dec. 10:

• $340,136,000 of 4.35% notes due March 15, 2014 to be redeemed at 105.106;

• $370,155,000 of 2.7% notes due May 27, 2015 to be redeemed at 105.667;

• $1,188,964,000 of 5.875% notes due May 15, 2016 to be redeemed at 118.094; and

• $875,235,000 of 5.6% notes due Nov. 30, 2017 to be redeemed at 123.017.

As previously reported, the company is redeeming the remaining notes following a tender offer, during which investors tendered $159,864,000 of the 4.35% notes, $379,845,000 of the 2.7% notes, $811,036,000 of the 5.875% notes and $624,765,000 of the 5.6% notes.

The Bank of New York Mellon Trust Co., NA is the trustee.

The pharmaceutical health care products company is based in Abbott Park, Ill.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.